Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1530804/000153080421000005/trox-20201231.htm
• |
Revenue of $783 million
|
• |
Income from operations of $94 million; Net income from continuing operations of $57 million
|
• |
Adjusted EBITDA of $204 million; Adjusted EBITDA margin of 26 percent (Non-GAAP)
|
• |
GAAP diluted EPS of $0.31; Adjusted diluted EPS of $0.19 (Non-GAAP)
|
• |
TiO2 selling prices remained level, benefiting from margin stability initiatives, and sales volumes increased 8 percent versus fourth quarter 2019 driven by improved market demand globally
|
• |
Zircon volumes increased 48 percent versus fourth quarter 2019 driven primarily by strong demand in China
|
• |
Revenue of $2,758 million
|
• |
Income from operations of $271 million; Net income from continuing operations of $995 million
|
• |
Adjusted EBITDA of $668 million; Adjusted EBITDA margin of 24 percent (Non-GAAP)
|
• |
GAAP diluted income per share from continuing operations of $6.69; Adjusted diluted EPS of $0.56 (Non-GAAP)
|
• |
Total acquisition synergies of $243 million achieved, exceeding run rate synergy target of $220 million set at Investor Day in 2019; $193 million reflected in EBITDA, exceeding $183 million target set on third quarter 2020 earnings call
|
• |
Cash flow provided by operating activities of $355 million; Free Cash Flow of $160 million (Non-GAAP)
|
• |
$200 million discretionary debt repayment made in December 2020
|
• |
$300 million discretionary debt repayment expected to be made by end of Q1 2021 from cash on the balance sheet
|
• |
Increased annualized dividend to $0.32 per share, equivalent to a 14 percent increase, effective when the normal first quarter 2021 dividend is expected to be declared
|
• |
Q1 2021 Outlook:
|
– |
TiO2 sales volumes expected to increase 11-15 percent sequentially from global demand strength
|
– |
Q1 2021 Adjusted EBITDA outlook of $200-$210 million
|
(Millions of dollars)
|
Q4 2020
|
Q4 2019
|
Y-o-Y
|
%∆
|
Q3 2020
|
Q-o-Q
|
%∆
|
|||||||||||||
Revenue
|
$
|
783
|
$
|
693
|
13
|
%
|
$
|
675
|
16
|
%
|
||||||||||
TiO2
|
587
|
544
|
8
|
%
|
543
|
8
|
%
|
|||||||||||||
Zircon
|
94
|
71
|
32
|
%
|
56
|
68
|
%
|
|||||||||||||
Feedstock and other products
|
102
|
78
|
31
|
%
|
76
|
34
|
%
|
|||||||||||||
Net Income from Continuing Ops
|
57
|
1
|
n/
|
m
|
902
|
n/
|
m
|
|||||||||||||
Adjusted EBITDA
|
204
|
156
|
31
|
%
|
148
|
38
|
%
|
|||||||||||||
Adjusted EBITDA Margin %
|
26
|
%
|
23
|
%
|
3 pts
|
22
|
%
|
4 pts
|
||||||||||||
Y-o-Y% ∆ | Q-o-Q% ∆ | ||||||||||||||||
Volume
|
Price
|
Volume
|
Price
|
||||||||||||||
TiO2
|
8
|
%
|
0
|
%
|
8
|
%
|
0
|
%
|
|||||||||
Local Currency Basis
|
n/a
|
(2
|
%)
|
n/a
|
0
|
%
|
|||||||||||
Zircon
|
48
|
%
|
(10
|
%)
|
70
|
%
|
(2
|
%)
|
• |
Revenue of $783 million increased 13 percent compared to $693 million
|
• |
TiO2 sales of $587 million increased 8 percent compared to $544 million; sales volumes increased 8 percent versus the year ago quarter driven by market recovery and a positive deviation from normal seasonal trends; selling
prices remain unchanged on a U.S. dollar basis and declined 2 percent on a local currency basis year over year
|
• |
Zircon sales of $94 million increased 32 percent from $71 million; sales volumes improved 48 percent primarily due to demand recovery in China while selling prices were 10 percent lower
|
• |
Feedstock and other products sales of $102 million increased 31 percent from $78 million due to improved pig iron demand
|
• |
Adjusted EBITDA of $204 million increased 31 percent compared to $156 million, driven primarily by higher sales volumes, acquisition synergies, and favorable exchange rates, partially offset by lower pricing and increased production
costs due to higher fixed cost absorption; includes $4 million of reimbursement from claims related to the Ginkgo concentrator failure we inherited as part of the Cristal transaction
|
• |
Selling, general and administrative (“SG&A”) expenses were $84 million compared to $92 million
|
• |
Interest expense of $49 million increased from $47 million in the year-ago quarter
|
• |
Revenue of $783 million increased 16 percent compared to $675 million
|
• |
TiO2 sales of $587 million increased 8 percent compared to $543 million; sales volumes increased 8 percent driven by continued recovery across all markets and geographies and a positive deviation from normal seasonal trends;
selling prices remained level sequentially on both a U.S. dollar and local basis
|
• |
Zircon sales of $94 million increased 68 percent from $56 million, driven by a 70 percent increase in sales volumes due to demand recovery in China and some benefit from shipment timing between quarters while selling prices declined 2
percent
|
• |
Feedstock and other products sales of $102 million increased 34 percent compared to $76 million, due to improved sales volumes of pig iron
|
• |
Adjusted EBITDA of $204 million increased 38 percent compared to $148 million, driven primarily by improved sales volumes, improved production costs, and synergies, partially offset by exchange rate headwinds; includes $4 million of
reimbursement from claims related to the Ginkgo concentrator failure we inherited as part of the Cristal transaction
|
• |
SG&A expenses were $84 million compared to $89 million
|
• |
Interest expense was $49 million compared to $48 million
|
• |
As of December 31, 2020, debt was $3.3 billion and debt, net of cash and cash equivalents was $2.7 billion
|
• |
Liquidity was $1.0 billion as of December 31, 2020, comprised of cash and cash equivalents of $619 million and $422 million available under revolving credit agreements
|
• |
Restricted cash of $29 million includes $18 million which was released as a break fee in January 2021 related to the TTI acquisition
|
• |
FY 2020 capital expenditures were $195 million
|
• |
FY 2020 depreciation, depletion and amortization expense was $304 million
|
• |
Free Cash Flow for the year was $160 million
|
• |
Alembic Global Advisors Chemical & Industrial Conference (Virtual), February 26, 2021
|
• |
NYSE Basic Materials Access Day (Virtual), March 9, 2021
|
• |
Fermium ESG Forum (Virtual), March 24, 2021
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
Net sales
|
$
|
783
|
$
|
693
|
$
|
2,758
|
$
|
2,642
|
||||||||
Cost of goods sold
|
605
|
545
|
2,137
|
2,159
|
||||||||||||
Contract loss
|
-
|
-
|
-
|
19
|
||||||||||||
Gross profit
|
178
|
148
|
621
|
464
|
||||||||||||
Selling, general and administrative expenses
|
84
|
95
|
347
|
347
|
||||||||||||
Restructuring
|
-
|
9
|
3
|
22
|
||||||||||||
Income from operations
|
94
|
44
|
271
|
95
|
||||||||||||
Interest expense
|
(49
|
)
|
(47
|
)
|
(189
|
)
|
(201
|
)
|
||||||||
Interest income
|
2
|
2
|
8
|
18
|
||||||||||||
Loss on extinguishment of debt
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
||||||||
Other income (expense), net
|
7
|
1
|
26
|
3
|
||||||||||||
Income (loss) from continuing operations before income taxes
|
52
|
(1
|
)
|
114
|
(88
|
)
|
||||||||||
Income tax benefit (provision)
|
5
|
(4
|
)
|
881
|
(14
|
)
|
||||||||||
Net income (loss) from continuing operations
|
57
|
(5
|
)
|
995
|
(102
|
)
|
||||||||||
Net income from discontinued operations, net of tax
|
-
|
-
|
-
|
5
|
||||||||||||
Net income (loss)
|
57
|
(5
|
)
|
995
|
(97
|
)
|
||||||||||
Net income attributable to noncontrolling interest
|
12
|
(5
|
)
|
26
|
12
|
|||||||||||
Net income (loss) attributable to Tronox Holdings plc
|
$
|
45
|
$
|
-
|
$
|
969
|
$
|
(109
|
)
|
|||||||
Net income (loss) per share, basic:
|
||||||||||||||||
Continuing operations
|
$
|
0.31
|
$
|
-
|
$
|
6.76
|
$
|
(0.81
|
)
|
|||||||
Discontinued operations
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
0.03
|
||||||||
Net income (loss) per share, basic
|
$
|
0.31
|
$
|
-
|
$
|
6.76
|
$
|
(0.78
|
)
|
|||||||
Net income (loss) per share, diluted:
|
||||||||||||||||
Continuing operations
|
$
|
0.31
|
$
|
-
|
$
|
6.69
|
$
|
(0.81
|
)
|
|||||||
Discontinued operations
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
0.03
|
||||||||
Net income (loss) per share, diluted
|
$
|
0.31
|
$
|
-
|
$
|
6.69
|
$
|
(0.78
|
)
|
|||||||
Weighted average shares outstanding, basic (in thousands)
|
143,621
|
141,923
|
143,355
|
139,859
|
||||||||||||
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
141,923
|
144,906
|
139,859
|
||||||||||||
Other Operating Data:
|
||||||||||||||||
Capital expenditures
|
66
|
58
|
195
|
198
|
||||||||||||
Depreciation, depletion and amortization expense
|
85
|
75
|
304
|
280
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
Net income (loss) attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
45
|
$
|
-
|
$
|
969
|
$
|
(109
|
)
|
|||||||
Net income from discontinued operations, net of tax (U.S. GAAP)
|
-
|
-
|
-
|
5
|
||||||||||||
Net income (loss) from continuing operations attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
45
|
$
|
-
|
$
|
969
|
$
|
(114
|
)
|
|||||||
Inventory step-up (a)
|
-
|
2
|
-
|
91
|
||||||||||||
Contract loss (b)
|
-
|
-
|
-
|
14
|
||||||||||||
Transaction costs (c)
|
4
|
3
|
14
|
32
|
||||||||||||
Restructuring (d)
|
-
|
8
|
3
|
21
|
||||||||||||
Integration costs (e)
|
-
|
8
|
10
|
16
|
||||||||||||
Loss on extinguishment of debt (f)
|
2
|
1
|
2
|
3
|
||||||||||||
Pension settlement and curtailment gains (g)
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
Insurance proceeds (h)
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
Other (i)
|
2
|
-
|
4
|
-
|
||||||||||||
Tax valuation allowance (j)
|
(10
|
)
|
-
|
(903
|
)
|
-
|
||||||||||
Charge for capital gains tax payment to Exxaro (k)
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
Income tax expense - deferred tax assets (l)
|
(5
|
)
|
-
|
(5
|
)
|
-
|
||||||||||
Adjusted net income from continuing operations attributable to Tronox Holdings plc (non-U.S. GAAP) (1)(2)
|
$
|
28
|
$
|
19
|
$
|
81
|
$
|
66
|
||||||||
Diluted net income (loss) per share from continuing operations (U.S. GAAP)
|
$
|
0.31
|
$
|
-
|
$
|
6.69
|
$
|
(0.81
|
)
|
|||||||
Inventory step-up, per share
|
-
|
0.01
|
-
|
0.65
|
||||||||||||
Contract loss, per share
|
-
|
-
|
-
|
0.10
|
||||||||||||
Transaction costs, per share
|
0.03
|
0.02
|
0.10
|
0.23
|
||||||||||||
Restructuring, per share
|
-
|
0.06
|
0.02
|
0.15
|
||||||||||||
Integration costs, per share
|
-
|
0.06
|
0.07
|
0.11
|
||||||||||||
Loss on extinguishment of debt, per share
|
0.01
|
0.01
|
0.01
|
0.02
|
||||||||||||
Pension settlement and curtailment gains, per share
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
||||||||
Insurance proceeds, per share
|
(0.05
|
)
|
-
|
(0.08
|
)
|
-
|
||||||||||
Other, per share
|
0.01
|
-
|
0.03
|
-
|
||||||||||||
Tax valuation allowance, per share
|
(0.07
|
)
|
-
|
(6.24
|
)
|
-
|
||||||||||
Charge for capital gains tax payment to Exxaro, per share
|
-
|
(0.01
|
)
|
-
|
0.03
|
|||||||||||
Income tax expense - deferred tax assets, per share
|
(0.04
|
)
|
-
|
(0.03
|
)
|
-
|
||||||||||
Diluted adjusted net income per share from continuing operations attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
0.19
|
$
|
0.14
|
$
|
0.56
|
$
|
0.47
|
||||||||
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
143,124
|
144,906
|
140,961
|
December 31, 2020
|
December 31, 2019
|
|||||||
ASSETS
|
||||||||
Current Assets
|
||||||||
Cash and cash equivalents
|
$
|
619
|
$
|
302
|
||||
Restricted cash
|
29
|
9
|
||||||
Accounts receivable (net of allowance of $5 in 2020 and $5 in 2019)
|
540
|
482
|
||||||
Inventories, net
|
1,137
|
1,131
|
||||||
Prepaid and other assets
|
200
|
143
|
||||||
Income taxes receivable
|
4
|
6
|
||||||
Total current assets
|
2,529
|
2,073
|
||||||
Noncurrent Assets
|
||||||||
Property, plant and equipment, net
|
1,759
|
1,762
|
||||||
Mineral leaseholds, net
|
803
|
852
|
||||||
Intangible assets, net
|
201
|
208
|
||||||
Lease right of use assets, net
|
81
|
101
|
||||||
Deferred tax assets
|
1,020
|
110
|
||||||
Other long-term assets
|
175
|
162
|
||||||
Total assets
|
$
|
6,568
|
$
|
5,268
|
||||
LIABILITIES AND EQUITY
|
||||||||
Current Liabilities
|
||||||||
Accounts payable
|
$
|
356
|
$
|
342
|
||||
Accrued liabilities
|
350
|
283
|
||||||
Short-term lease liabilities
|
39
|
38
|
||||||
Long-term debt due within one year
|
58
|
38
|
||||||
Income taxes payable
|
2
|
1
|
||||||
Total current liabilities
|
805
|
702
|
||||||
Noncurrent Liabilities
|
||||||||
Long-term debt, net
|
$
|
3,263
|
$
|
2,988
|
||||
Pension and postretirement healthcare benefits
|
146
|
160
|
||||||
Asset retirement obligations
|
157
|
142
|
||||||
Environmental liabilities
|
67
|
65
|
||||||
Long-term lease liabilities
|
41
|
62
|
||||||
Deferred tax liabilities
|
176
|
184
|
||||||
Other long-term liabilities
|
42
|
49
|
||||||
Total liabilities
|
4,697
|
4,352
|
||||||
Commitments and Contingencies
|
||||||||
Shareholders’ Equity
|
||||||||
Tronox Holdings plc ordinary shares, par value $0.01 — 143,557,479 shares issued and outstanding at December 31, 2020 and 141,900,459 shares issued and outstanding at December 31, 2019
|
1
|
1
|
||||||
Capital in excess of par value
|
1,873
|
1,846
|
||||||
Retained Earnings (accumulated deficit)
|
434
|
(493
|
)
|
|||||
Accumulated other comprehensive loss
|
(610
|
)
|
(606
|
)
|
||||
Total Tronox Holdings plc shareholders’ equity
|
1,698
|
748
|
||||||
Noncontrolling interest
|
173
|
168
|
||||||
Total equity
|
1,871
|
916
|
||||||
Total liabilities and equity
|
$
|
6,568
|
$
|
5,268
|
Year Ended December 31,
|
||||||||
2020
|
2019
|
|||||||
Cash Flows from Operating Activities:
|
||||||||
Net (loss) income
|
$
|
995
|
$
|
(97
|
)
|
|||
Net income (loss) from discontinued operations, net of tax
|
-
|
$
|
5
|
|||||
Net (loss) income from continuing operations
|
$
|
995
|
$
|
(102
|
)
|
|||
Adjustments to reconcile net (loss) income from continuing operations to net cash provided by operating activities, continuing operations:
|
||||||||
Depreciation, depletion and amortization
|
304
|
280
|
||||||
Deferred income taxes
|
(899
|
)
|
(9
|
)
|
||||
Share-based compensation expense
|
30
|
32
|
||||||
Amortization of deferred debt issuance costs and discount on debt
|
10
|
8
|
||||||
Loss on extinguishment of debt
|
2
|
3
|
||||||
Contract loss
|
-
|
19
|
||||||
Impairment loss
|
-
|
-
|
||||||
Acquired inventory step-up recognized in earnings
|
-
|
98
|
||||||
Other non-cash affecting net income (loss)
|
65
|
25
|
||||||
Changes in assets and liabilities:
|
||||||||
(Increase) decrease in accounts receivable, net
|
(49
|
)
|
78
|
|||||
(Increase) decrease in inventories, net
|
(21
|
)
|
(59
|
)
|
||||
(Increase) decrease in prepaid and other assets
|
(29
|
)
|
20
|
|||||
Increase (decrease) in accounts payable and accrued liabilities
|
17
|
67
|
||||||
Net changes in income tax payables and receivables
|
(2
|
)
|
(13
|
)
|
||||
Changes in other non-current assets and liabilities
|
(68
|
)
|
(35
|
)
|
||||
Cash provided by operating activities – continuing operations
|
355
|
412
|
||||||
Cash Flows from Investing Activities:
|
||||||||
Capital expenditures
|
(195
|
)
|
(198
|
)
|
||||
Cristal Acquisition
|
-
|
(1,675
|
)
|
|||||
Proceeds from sale of Ashtabula
|
-
|
701
|
||||||
Insurance proceeds
|
1
|
10
|
||||||
Proceeds from sale of businesses
|
-
|
-
|
||||||
Loans
|
(36
|
)
|
(25
|
)
|
||||
Proceeds from the sale of assets
|
1
|
2
|
||||||
Cash used in investing activities – continuing operations
|
(229
|
)
|
(1,185
|
)
|
||||
Cash Flows from Financing Activities:
|
||||||||
Repayments of short-term debt
|
(13
|
)
|
0
|
|||||
Repayments of long-term debt
|
(233
|
)
|
(387
|
)
|
||||
Proceeds from short-term debt
|
13
|
-
|
||||||
Proceeds from long-term debt
|
500
|
222
|
||||||
Repurchase of common stock
|
-
|
(288
|
)
|
|||||
Acquisition of noncontrolling interest
|
-
|
(148
|
)
|
|||||
Debt issuance costs
|
(10
|
)
|
(4
|
)
|
||||
Call premium paid
|
-
|
-
|
||||||
Dividends paid
|
(40
|
)
|
(27
|
)
|
||||
Restricted stock and performance-based shares settled in cash for taxes
|
(3
|
)
|
(6
|
)
|
||||
Proceeds from the exercise of warrants and options
|
-
|
-
|
||||||
Cash provided by (used in) financing activities – continuing operations
|
214
|
(638
|
)
|
|||||
Discontinued Operations:
|
||||||||
Cash provided by operating activities
|
-
|
29
|
||||||
Cash used in investing activities
|
-
|
(1
|
)
|
|||||
Net cash flows provided by discontinued operations
|
-
|
28
|
||||||
Effects of exchange rate changes on cash and cash equivalents and restricted cash
|
(3
|
)
|
(2
|
)
|
||||
Net increase (decrease) in cash and cash equivalents and restricted cash
|
337
|
(1,385
|
)
|
|||||
Cash and cash equivalents and restricted cash at beginning of period
|
311
|
1,696
|
||||||
Cash and cash equivalents and restricted cash at end of period - continuing operations
|
$
|
648
|
$
|
311
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
Net income (loss) (U.S. GAAP)
|
$
|
57
|
$
|
(5
|
)
|
$
|
995
|
$
|
(97
|
)
|
||||||
Income from discontinued operations, net of tax (U.S. GAAP)
|
-
|
-
|
-
|
5
|
||||||||||||
Net income (loss) from continuing operations (U.S. GAAP)
|
$
|
57
|
$
|
(5
|
)
|
$
|
995
|
$
|
(102
|
)
|
||||||
Interest expense
|
49
|
47
|
189
|
201
|
||||||||||||
Interest income
|
(2
|
)
|
(2
|
)
|
(8
|
)
|
(18
|
)
|
||||||||
Income tax provision (benefit)
|
(5
|
)
|
4
|
(881
|
)
|
14
|
||||||||||
Depreciation, depletion and amortization expense
|
85
|
75
|
304
|
280
|
||||||||||||
EBITDA (non-U.S. GAAP)
|
184
|
119
|
599
|
375
|
||||||||||||
Inventory step-up (a)
|
-
|
3
|
-
|
98
|
||||||||||||
Contract loss (b)
|
-
|
-
|
-
|
19
|
||||||||||||
Share-based compensation (c)
|
11
|
8
|
30
|
32
|
||||||||||||
Transaction costs (d)
|
4
|
3
|
14
|
32
|
||||||||||||
Restructuring (e)
|
-
|
9
|
3
|
22
|
||||||||||||
Integration costs (f)
|
-
|
8
|
10
|
16
|
||||||||||||
Loss on extinguishment of debt (g)
|
2
|
1
|
2
|
3
|
||||||||||||
Foreign currency remeasurement (h)
|
6
|
(1
|
)
|
(4
|
)
|
(6
|
)
|
|||||||||
Pension settlement and curtailment gains (i)
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
Charge for capital gains tax payment to Exxaro (j)
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
Insurance proceeds(k)
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
Other items (l)
|
7
|
9
|
27
|
21
|
||||||||||||
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
204
|
$
|
156
|
$
|
668
|
$
|
615
|
Consolidated
|
||||
Cash provided by operating activities - continuing operations
|
$
|
355
|
||
Capital expenditures
|
(195
|
)
|
||
Free cash flow (non-U.S. GAAP)
|
$
|
160
|
Proforma amounts
|
Proforma amounts
|
|||||||||||||||
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
Net sales
|
$
|
783
|
$
|
693
|
$
|
2,758
|
$
|
3,008
|
||||||||
Cost of goods sold
|
605
|
542
|
2,137
|
2,364
|
||||||||||||
Gross profit
|
178
|
151
|
621
|
644
|
||||||||||||
Selling, general and administrative expenses
|
84
|
92
|
347
|
354
|
||||||||||||
Restructuring
|
-
|
9
|
3
|
22
|
||||||||||||
Income from operations
|
94
|
50
|
271
|
268
|
||||||||||||
Interest expense
|
(49
|
)
|
(47
|
)
|
(189
|
)
|
(207
|
)
|
||||||||
Interest income
|
2
|
2
|
8
|
12
|
||||||||||||
Loss on extinguishment of debt
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(3
|
)
|
||||||||
Other expense, net
|
7
|
1
|
26
|
2
|
||||||||||||
Income from continuing operations before income taxes
|
52
|
5
|
114
|
72
|
||||||||||||
Income tax benefit (provision)
|
5
|
(4
|
)
|
881
|
(31
|
)
|
||||||||||
Net income from continuing operations
|
57
|
1
|
995
|
41
|
||||||||||||
Net income attributable to noncontrolling interest
|
12
|
5
|
26
|
23
|
||||||||||||
Net income from continuing operations attributable to Tronox Holdings plc
|
$
|
45
|
$
|
(4
|
)
|
$
|
969
|
$
|
18
|
|||||||
Net income from continuing operations per share, diluted
|
$
|
0.31
|
$
|
(0.03
|
)
|
$
|
6.69
|
$
|
0.12
|
|||||||
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
141,923
|
144,906
|
151,153
|
Proforma amounts
|
Proforma amounts
|
|||||||||||||||
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
Net income from continuing operations attributable to Tronox Holdings plc (U.S. GAAP)
|
$
|
45
|
$
|
(4
|
)
|
$
|
969
|
$
|
18
|
|||||||
Transaction costs
|
4
|
-
|
14
|
-
|
||||||||||||
Restructuring
|
-
|
8
|
3
|
21
|
||||||||||||
Integration costs
|
-
|
8
|
10
|
16
|
||||||||||||
Loss on extinguishment of debt
|
2
|
1
|
2
|
3
|
||||||||||||
Pension settlement and curtailment gains
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
Insurance proceeds
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
Other
|
2
|
-
|
4
|
-
|
||||||||||||
Tax valuation allowance
|
(10
|
)
|
-
|
(903
|
)
|
-
|
||||||||||
Income tax expense - deferred tax assets
|
(5
|
)
|
-
|
(5
|
)
|
-
|
||||||||||
Charge for capital gains tax payment to Exxaro
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
Adjusted net income attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
28
|
$
|
10
|
$
|
81
|
$
|
61
|
||||||||
Diluted net income per share from continuing operations (U.S. GAAP)
|
$
|
0.31
|
$
|
(0.03
|
)
|
$
|
6.69
|
$
|
0.12
|
|||||||
Transaction costs, per share
|
0.03
|
-
|
0.10
|
-
|
||||||||||||
Restructuring, per share
|
-
|
0.06
|
0.02
|
0.13
|
||||||||||||
Integration costs, per share
|
-
|
0.06
|
0.07
|
0.10
|
||||||||||||
Loss on extinguishment of debt, per share
|
0.01
|
0.01
|
0.01
|
0.02
|
||||||||||||
Pension settlement and curtailment gains, per share
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
(0.01
|
)
|
||||||||
Insurance proceeds, per share
|
(0.05
|
)
|
-
|
(0.08
|
)
|
-
|
||||||||||
Other, per share
|
0.01
|
-
|
0.03
|
-
|
||||||||||||
Tax valuation allowance, per share
|
(0.07
|
)
|
-
|
(6.24
|
)
|
-
|
||||||||||
Income tax expense - deferred tax assets, per share
|
(0.04
|
)
|
-
|
(0.03
|
)
|
-
|
||||||||||
Charge for capital gains tax payment to Exxaro, per share
|
-
|
(0.02
|
)
|
-
|
0.03
|
|||||||||||
Diluted adjusted net income per share attributable to Tronox Holdings plc (non-U.S. GAAP)
|
$
|
0.19
|
$
|
0.07
|
$
|
0.56
|
$
|
0.39
|
||||||||
Weighted average shares outstanding, diluted (in thousands)
|
147,254
|
143,124
|
144,906
|
151,153
|
Three Months Ended December 31,
|
Year Ended December 31,
|
|||||||||||||||
2020
|
2019
|
2020
|
2019
|
|||||||||||||
Net income from continuing operations (U.S. GAAP)
|
$
|
57
|
$
|
1
|
$
|
995
|
$
|
41
|
||||||||
Interest expense
|
49
|
47
|
189
|
207
|
||||||||||||
Interest income
|
(2
|
)
|
(2
|
)
|
(8
|
)
|
(12
|
)
|
||||||||
Income tax provision (benefit)
|
(5
|
)
|
4
|
(881
|
)
|
31
|
||||||||||
Depreciation, depletion and amortization expense
|
85
|
75
|
304
|
323
|
||||||||||||
EBITDA (non-U.S. GAAP)
|
184
|
125
|
599
|
590
|
||||||||||||
Inventory step-up
|
-
|
-
|
-
|
-
|
||||||||||||
Share-based compensation
|
11
|
8
|
30
|
32
|
||||||||||||
Transaction costs
|
4
|
-
|
14
|
-
|
||||||||||||
Restructuring
|
-
|
9
|
3
|
22
|
||||||||||||
Integration costs
|
-
|
8
|
10
|
16
|
||||||||||||
Loss on extinguishment of debt
|
2
|
1
|
2
|
3
|
||||||||||||
Foreign currency remeasurement
|
6
|
(1
|
)
|
(4
|
)
|
(6
|
)
|
|||||||||
Pension settlement and curtailment gains
|
(2
|
)
|
(1
|
)
|
(2
|
)
|
(1
|
)
|
||||||||
Charge for capital gains tax payment to Exxaro
|
-
|
(2
|
)
|
-
|
4
|
|||||||||||
Insurance proceeds
|
(8
|
)
|
-
|
(11
|
)
|
-
|
||||||||||
Other items
|
7
|
9
|
27
|
21
|
||||||||||||
Adjusted EBITDA (non-U.S. GAAP)
|
$
|
204
|
$
|
156
|
$
|
668
|
$
|
681
|
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Tronox Ltd.
Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1530804/000153080421000005/trox-20201231.htm
Receive an e-mail as soon as a company files an Annual Report, Quarterly Report or has new 8-K corporate news.
ContinueRead positive and negative remarks made by management in their entirety without having to find them in a 10-K/Q.
ContinueRemove data columns and navigations in order to see much more filing content and tables in one view
ContinueRead both hidden opportunities and early signs of potential problems without having to find them in a 10-K/Q
ContinueExport Annual and Quarterly Reports to Adobe PDF, Microsoft Word and Excel for offline viewing, annotations and analysis
ContinueGet one-click access to balance sheets, income, operations and cash flow statements without having to find them in Annual and Quarterly Reports
Continue for FREEOur Intrinsic Value calculator estimates what an entire company is worth using up to 10 years of financial ratios to determine if a stock is overvalued or not
ContinueOur Financial Stability reports uses up to 10 years of financial ratios to determine the health of a company's EPS, Dividends, Book Value, Return on Equity, Current Ratio and Debt-to-Equity
ContinueSee how over 70
Growth, Profitability and Financial Ratios perform over 10 Years